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Abstract
Botulinum neurotoxin (BoNT) is one of the most toxic substances known. BoNT is classified into 
seven distinct serotypes labeled A through G. Among individual serotypes, researchers have 
identified subtypes based on amino acid variability within a serotype and toxin variants with 
minor amino acid sequence differences within a subtype. BoNT subtype identification is valuable 
for tracing and tracking bacterial pathogens. A proteomics approach is useful for BoNT subtyping 
since botulism is caused by botulinum neurotoxin and does not require the presence of the bacteria 
or its DNA. Enzymatic digestion and peptide identification using tandem mass spectrometry 
determines toxin protein sequences. But with the conventional one-step digestion method, 
producing sufficient numbers of detectable peptides to cover the entire protein sequence is 
difficult and incomplete sequence coverage results in uncertainty in distinguishing BoNT subtypes 
and toxin variants because of high sequence similarity. We report here a method of multiple 
enzymes and sequential in-gel digestion (MESID) to characterize the BoNT protein sequence. 
Complementary peptide detection from toxin digestions has yielded near-complete sequence 
coverage for all seven BoNT serotypes. Application of the method to a BoNT-contaminated carrot 
juice sample resulted in the identification of 98.4% protein sequence which led to a confident 
determination of the toxin subtype.
Introduction
The botulinum neurotoxins (BoNT) produced by Clostridium botulinum, C. baratii, C. 
butyricum, and C. argentinese are among the most toxic substances known and exposure 
results in the deadly flaccid muscular paralysis known as botulism.1 Human botulism 
consists of three main types: foodborne, infant and adult intestinal colonization, and wound. 
Due to BoNTs’ high toxicity and ease of preparation, they are considered potential 
bioterrorism agents and BoNTs are classified as category A agents.2
Full-length BoNTs are synthesized as a single protein of 150 kDa. The active BoNT form 
consists of two polypeptide chains linked through a disulfide bond. The light chain (50 kDa) 
is responsible for BoNT’s zinc-endopeptidase activity, which cleaves one or more cellular 
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targets essential for the release of a neurotransmitter (acetylcholine) in the nervous system. 
The heavy chain (100 kDa) is composed of an N-terminal translocation domain and a C-
terminal receptor binding domain.3 These domains play an essential role in the toxin’s 
transport into synaptic cells.
BoNTs are divided into seven distinct serotypes designated as A to G, according to their 
antigenic properties. Human botulism is generally associated with exposures to BoNTs of 
the serotypes A, B, E, and F. In addition to distinct serotypes, many BoNT subtypes have 
been recently identified based on their sequence variations and antigenic differences.4–6 For 
example, gene sequence analysis has identified five BoNT/A subtypes (A1 through A5).7–9 
Whereas the sequence similarity among different serotypes is relatively low, the subtypes 
within a BoNT serotype generally exhibit high sequence similarity. The BoNTs are futher 
divided into toxin variants that are based on minor sequence differences within a toxin 
subtype derived from different bacterial strains.
For public health emergencies and counter-bioterrorism purposes, rapid and accurate 
identification of the BoNT serotype, subtype, and variant can be critical for epidemiological 
purposes because these differences can rapidly identify similarities and differences between 
concurrent botulism outbreaks. Nucleotide sequencing of BoNT genes using polymerase 
chain reaction (PCR) or real-time PCR techniques can subtype BoNTs.10–15 More recently, 
researchers have reported a multiplex PCR assay for the detection and identification of 
BoNT subtypes.16–17 These PCR techniques require the presence of DNA, however. The 
disease botulism is caused by toxins and the toxin producing clostridial organisms and their 
DNA are not always present in outbreak associated samples.
Mass spectrometry (MS) has proven a powerful tool in the identification of amino acid 
sequences of proteins and peptides.18 In a bottom-up approach, proteolytic enzymes are used 
to digest proteins into peptides either in-solution or in-gel. Liquid chromatography coupled 
with tandem mass spectrometry (LC-MS/MS) in combination with database searching is 
used to determine the primary peptide sequence. Due to this technique’s high efficiency, 
high-throughput, and capability with complex samples, it has become one of the most 
powerful tools for protein identification, profiling, and quantification. We previously 
reported the differentiation of BoNT/A1 and BoNT/A2 in milk with MS based 
proteomics. 19 In that study, the peptides unique to a specific BoNT subtype were identified 
through LC-MS/MS analysis, allowing the determination of the BoNT/A subtype from the 
toxin itself. A limitation of many proteomic studies, however, is that the use of a single 
enzyme (e.g. trypsin) can result in a limited number of tryptic peptides resulting in low 
sequence coverage. The subtypes of BoNT serotypes often show a high level of sequence 
similarity with as little as 2.6% sequence difference and the toxin variants can vary by as 
little as a single amino acid. 9 Thus, identification of the toxin subtype/variant, which can be 
a critical factor in responding to and preventing public health emergencies, requires high 
sequence coverage to expose subtype/variant-specific amino acid variable sites and provide 
confident discrimination.
We describe here a multiple enzyme and sequential in-gel digestion approach that we term 
MESID. It was designed for subtyping botulinum neurotoxins with high sequence coverage 
Wang et al. Page 2
Anal Chem. Author manuscript; available in PMC 2015 September 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
and may prove useful to differentiate other toxins or human pathogens to aid public health 
tracking and disease prevention. We show that a combination of 1) multiple proteolytic 
enzymes with different specificities (trypsin, chymotrypsin, Asp-N, and Lys-C) and 2) three 
sequential digestions on a single 1D-PAGE band of the toxin can significantly increase 
toxin-protein sequence coverage.
Experimental Procedures
Materials
All chemicals were obtained from Sigma–Aldrich (St. Louis, MO) except where otherwise 
indicated. Endoproteases including trypsin, chymotrypsin, Asp-N, Lys-C, Glu-C and Arg-C 
were purchased from Roche Applied Science (Indianapolis, IN). BoNT/A, /B, /C, /D, /E, /F, 
and /G complexes were obtained from Metabiologics (Madison, WI). BoNT contaminated 
carrot juice obtained from bottles of carrot juice that were implicated in a botulism outbreak 
in 2006,20 was provided by the U. S. Food and Drug Administration.
1D Gel electrophoresis
SDS-PAGE gel electrophoresis was performed on a NuPAGE Novex Bis-Tris gel following 
the standard procedure (Invitrogen). In brief, 1μL of the toxin complex (1 mg/mL) was 
mixed with 2.5 μL of 4X sample buffer and 6.5 μL of deionized water and heated at 90 °C 
for 10 min. The toxin in the carrot juice sample was extracted by an antibody immobilized 
on the Protein G coupled Dynabeads (Invitrogen) as previously described19 and was eluted 
by incubating the beads in 10 μL of the sample buffer and heated to 90°C for 10 min. The 
eluted proteins were loaded on a 4–12% gradient gel. The gels were stained with a Silver 
Stain kit (Protea Biosciences, Morgantown, WV) following manufacturer’s protocol.
In-gel digestion of BoNTs
The gel bands of BoNT were sliced and each band was further cut into four equal pieces 
followed by destaining. The protein was reduced with 10 mM dithiothreitol at 60°C for 30 
min and alkylated with 55 mM iodoacetamide at room temperature in the dark for 30 min. 
For in-gel guanidination, the gels were incubated in a freshly prepared O-methylisourea 
solution (1.2M) at 65°C for 2 hours. The in-gel digestion was conducted in 20 μL of 
solutions containing 0.2 μg of the enzyme (trypsin, chymotrypsin, Asp-N, Lys-C, Arg-C or 
Glu-C) at various temperatures and reaction times as indicated. Sequential digestions were 
performed by redigesting each of the bands with a select number of enzymes after removing 
peptides extracted from previous digestion. In some cases, the particles of the same band 
were split for two subsequent in-gel digestions carried out separately using different 
enzymes and then recombined for the third digestion with a single protease. After each 
digestion, the supernatant was transferred to a new tube and the second extraction was 
conducted with 20μL of 50:50 water/acetonitrile solution. Extracted fractions were 
combined with the digestion supernatants. The peptides were vacuum-dried and resuspended 
in 15 μL of 0.1% formic acid.
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LC-MS/MS analysis
NanoESI LC-MS/MS analysis was performed on an LTQ-FT mass spectrometer (Thermo 
Scientific) connected with a nanoAcquity UPLC (Waters, Milford, MA). The protein digest 
(7 μL) was injected on a C18 column (100 μm × 100 mm, 1.7 μm, BEH130Å) and the 
peptides were separated using a linear gradient of 5–35% of buffer B (acetonitrile, 0.1% 
formic acid) in buffer A (95:5 water/acetonitrile, 0.1% formic acid) over 80 min at a flow 
rate of 0.5 μL/min. The data acquisition was performed on an Xcalibur system, using data-
dependent mode where the five highest-intensity precursors in an MS1 survey scan were 
isolated for collision-induced dissociation. The resulting MS/MS data were searched for 
protein candidates with a database searching against an in-house BoNT database using 
MASCOT software (Matrix Sciences, London, UK). The mass tolerance of precursor ions 
and fragment ions was 10 ppm and 0.8Da, respectively. Resulting peptides were filtered 
with a significance threshold of p<0.05 and an ion score cut-off of 40. The peptides with ion 
scores of less than 50 were validated by manual inspection.
Results
In-gel digestion using multiple enzymes
To evaluate whether the multi-enzyme digestion might improve BoNT coverage, we initially 
used six common proteases including trypsin, Lys-C, Arg-C, chymotrypsin, Asp-N and Glu-
C, for the in-gel digestion of BoNT/A1 protein. Digestion of the toxin embedded in six 
identical gel bands was carried out with individual enzymes followed by LC-MS/MS 
analysis. As expected, different sequence coverage (1–59%) for the toxin protein was 
observed, depending on individual enzyme specificity and digestion efficiency (Table 1). By 
combining the data of the six digestions, a 72% overlapped sequence coverage was obtained. 
This result demonstrates that the multi-enzyme strategy can, through LC-MS/MS analysis, 
improve significantly the sequence coverage of botulinum neurotoxins. Further analysis of 
the peptides derived from these digestions revealed that some but not all of the six proteases 
produced unique peptides that were absent in other digestions. This contributed to the 
merged sequence’s extension of coverage.
In this study, we defined a “unique peptide” as one produced exclusively by a given enzyme 
and whose sequence contained amino acid residues not determined by other enzyme 
digestions. In-gel digestions by trypsin, chymotrypsin, Lys-C, or Asp-N added to the overall 
coverage 11 to 287 “unique peptide”-determined unique amino acid residues. In contrast and 
under the experimental conditions used, Arg-C and Glu-C digestion did not contribute any 
unique residues towards the overall sequence coverage. In-silico digestion of BoNT/A1 also 
indicates the sequence coverage derived from the theoretical digestion by either of those two 
proteases would be lower compared with the other four enzymes (Table 1). Therefore, Arg-
C and Glu-C were excluded from further studies as described below.
Sequential in-gel digestion
The efficiency of in-gel digestion is sometimes lower than in-solution digestion which can 
result in fewer peptides being identified by LC-MS/MS following in-gel digestion. This 
phenomenon may be caused by a variety of factors including low enzyme accessibility to the 
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proteins embedded inside the gel, peptide loss during post-digestion extraction, or a 
combination of both. Consequently, undigested intact protein and large fragment pieces 
resulting from partial digestion could possibly remain within the gel matrix. We theorized 
that additional digestion applied to an already digested gel band might yield new MS 
detectable peptides from the cleavage of the intact or partial protein fragments remaining in 
the gel matrix. To investigate this hypothesis, we examined the sequential digestions on the 
same gel band of a BoNT/A1 protein using various digestion hierarchies with identical or 
different proteases. Each of the first in-gel digestions on four identical gel bands of 
BoNT/A1 was carried out with one of the selected individual proteases including trypsin, 
chymotrypsin, Asp-N, and Lys-C. After the completion of each digest reaction, the solution 
containing the extracted peptides from the gel was removed. The gel bands were then 
immersed into a new reaction solution for the second or further digestions using the next 
digestion enzyme. Figure 1 contains the results of the four sets of the sequential in-gel 
digestions, where the sequence coverage for each successive individual digestion is summed 
with the preceding digestion results. It was observed that the second and the third digestions 
resulted in elevated sequence coverage. This suggested that additional digestions indeed 
generated unique peptides that improve the sequence coverage. It was noted that under the 
tested conditions, the fourth digestion in all the sets yielded no additional sequence coverage 
improvement. To get in-depth information on the origin of the peptides extracted from the 
second and third digestion, we examined the specificity of the peptides yielded from one 
sequential digestion set (Chymotrypsin-Trypsin-AspN-LysC) by checking their sequences 
and terminal residues at both ends. All the second-digestion peptides were identified as 
unique tryptic peptides that were not detected in the first digestion with chymotrypsin, 
whereas 31 of the 49 peptides identified in the third Asp-N digestion were new peptides 
(Table 2). These data reveal that most of the detected peptides after the second or third 
digestion were created by the cleavage of the intact protein or fragments retained in the gels. 
In addition, the newly generated peptides in the second or third digestion displayed different 
specificities through their terminal residues. For example, 22 of the 78 peptides yielded in 
the second digestion contained one trypsin-specific terminus. The other terminus was from a 
specific chymotrypsin cleavage, implying that those should be the peptides digested from 
the large fragments yielded by the first chymotrypsin digestion. A similar phenomenon was 
observed in the third digestion, where 20 of the 31 new peptides had an Asp-N specific 
terminus and a trypsin or chymotrypsin-specific residue at the other terminus. These results 
confirm that the low efficiency or sensitivity of conventional in-gel digestion might arise 
from incomplete cleavages of the target proteins and extraction of large digests. Thus, 
sequential digestion performed on a previously digested gel piece is a useful technique to 
increase further cleavages of undigested or partially digested proteins and newly generated 
peptides will result in more sequence information.
Combination of multi-enzyme and sequential in-gel digestion
A systematic study was conducted to assess the effect of different combinations of enzymes, 
sequential orders, and reaction conditions on the characterization of the BoNT/A1 protein. 
In an attempt to obtain complementary results from a single sample, we used two different 
proteases, each to a split sample for the second digestion. To reduce the time required for 
sample preparation and instrument operation, split samples were combined for the third 
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digestion with trypsin. Although one of the samples (S1, Table S1) underwent trypsin 
cleavage in the first digestion, this protease was used again in the third digestion with the 
expectation that the enzyme could access and cleave the newly formed protein fragments 
produced in the second digestion. For the same enzyme in each experimental sequence, 
different reaction times and temperatures were used to assure that the overall experiment 
including gel electrophoresis and in-gel digestions were optimized and could be finished in 2 
days. As expected, in almost all the samples the second and third digestions of each 
individual combination set led to sequence coverage expansion (Table S1). These data 
further confirm the enhancement of multi-enzyme and sequential digestion in protein 
sequence coverage as described above. An interesting point was to see that in some cases, 
the second split sample digestion improved the sequence coverage for BoNT. For instance, 
sample S4’s identified sequence region increased from 79% of the first Asp-N digestion to 
88% after the second chymotrypsin digestion on one half of the gel band, and to 85% of the 
Lys-C cleavage on the other half of the gel band, respectively. Overlapping regions from the 
two combinations further extended the sequence coverage to 90%, indicating the usefulness 
of splitting one gel band for different digestion sequences.
A combined effort on the use of multiple enzymes and sequential digestion of a single gel 
band resulted in a higher sequence coverage (up to 93%) than any single enzyme used for a 
single digestion event. The combination of two or more sequential digestion sets further 
elevated the sequence coverage (Table 3). For example, overlapped coverage of the toxin in 
the gel band S2 (initially digested by chymotrypsin) and in the band S4 (first digested by 
Asp-N) after the first (81%), second (96%) and third digestion (97%) were higher than 
corresponding values of either S2 or S4 alone. Moreover, different combinations could 
obtain similar coverage. The combination of the first digestions of S1, S2, and S4 generated 
a sequence coverage (97%) identical to that obtained from merging the data of S1 and S4, or 
S3 and S4 after the first two digestions. This indicates potential flexibility in experiment 
design based on the availability of sample quantity or on other factors that might need 
consideration. As a result of combing all data from the four experimental sets, 1285 of 1295 
total amino acid residues of the 150 kDa BoNT/A1 protein were covered by MS-identified 
peptides. In contrast to 76% coverage of the protein from a single step trypsin digestion, this 
near-complete (99%) sequence identification should enable highly confident determinations 
of known or unknown BoNT subtypes and toxin variants.
Chemical derivatization by guanidination
Previous studies reported that guanidination of lysine residues in tryptic peptides enhance 
their ionization efficiency and hence facilitate the detection of such peptides by mass 
spectrometry.21 To study the effect of this derivatization for improving sequence coverage 
in the present method, we applied guanidination to a gel band of the toxin before digestion. 
We observed that the derivatization resulted in more identified peptides and led to improved 
sequence coverage in a sequential digestion initiated with trypsin digestion (Figure 2). In 
comparison with the result from the sample without modification, digestion of guanidinated 
protein yielded higher sequence coverage at each individual digestion stage and produced 
higher overall sequence coverage as well. Note, however, that guanidination on the samples 
initially digested by other enzymes did not result in changes as significant as on the first 
Wang et al. Page 6
Anal Chem. Author manuscript; available in PMC 2015 September 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
trypsin sample (data not shown). Yet these data do demonstrate that to enhance protein 
sequencing further, guanidination of lysine residues of a protein could be a useful part of the 
MESID method.
Application on other serotypes of BoNTs
We examined next the suitability of the MESID method to other botulinum neurotoxins. 
Seven serotypes of commercially available BoNT complex were loaded on a one-
dimensional SDS gel, and the toxins were well separated from associated protein (Figure 
S1). Referring to the results of previous studies described above, we selected three sets of 
different enzyme combinations for each of the BoNT/A-G bands (Figure S2). As shown in 
Table 4, all of seven serotypes of BoNT proteins were identified with high sequence 
coverage (90–99%). Very high MASCOT scores (> 10,000) confirmed the confident 
identification. These results suggest that the new method can become a useful tool for 
subtyping all botulinum neurotoxins.
Subtyping of a BoNT-contaminated carrot juice sample
We used the MESID method to characterize the sequence of the BoNT present in a toxin-
contaminated carrot juice sample associated with botulism outbreaks in the US and Canada. 
The sample was previously determined to contain BoNT A by the Endopep-MS assay22 and 
the mouse assay and was subjected to MESID to obtain further information on the toxin 
subtype and variant on protein level. The toxin was extracted with antibody-coated beads 
and three identical samples were loaded into a 1D SDS gel (Figure S3). Following our 
optimized procedure (Figure S2), a pool of MS-detected peptides generated from the three 
sets of multi-enzyme, sequential in-gel digestions of the toxin containing gel bands 
confirmed that the target toxin was serotype A of BoNT (Table S2). The detected 98.6% 
sequence coverage determined by the 1082 unique peptides enabled identification of this 
toxin as the subtype BoNT/A1 (GeneBank accession no: ABY56330), consistent with the 
result of DNA sequencing23. Figure 3 shows the sequence alignment of the identified toxin 
and two homologues of the BoNT/A1 toxin variants (Accession no: ABZ80564 and 
YP_001383190). The identified sequence shared 99.9% and 99.6% identity with the two 
variants, respectively. Among the 1295 amino acid residues, only one variation is present at 
position 540 between the toxins ABY56330 and ABZ80564, while only five different 
residues are present between the toxin variants ABY56330 and YP_001383190. The 
identification of the unique peptides that covered those variable regions enabled the 
differentiation of such highly similar proteins and thus allowed not only the determination of 
the BoNT subtype but also toxin variant (ABY56330) as well.
Discussion
Unequally distributed proteolytic cleavage sites over the BoNT molecules, however, make it 
almost impossible to accomplish complete sequence coverage using only a single protease in 
an MS-based subtyping method. For example, trypsin cleaves proteins specifically at the C-
terminal sites of lysine and arginine residues. This almost always generates some tryptic 
fragments that are either too small, too large, or peptides with low ionization efficiency for 
detection by LC-MS/MS. A multiple enzyme digestion strategy is an effective way to 
Wang et al. Page 7
Anal Chem. Author manuscript; available in PMC 2015 September 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
overcome the limitations of single enzyme cleavage and a similar strategy has been 
successfully used in identification of post-translational modifications and in complete 
sequencing of some purified proteins.24–26 In this method, a sample can be divided into two 
or more parts and each part is digested with a protease that has different specificity. The 
digestion by multiple proteases usually generates overlapping peptides spanning a broader 
region of the target protein through cleavages at different residue-specific sites.
We examined here the effects of the multi-enzyme digestion on the gel bands of the 
BoNT/A1 protein. The combination of the individual digestions with four different enzymes 
resulted in the identification of more detectable peptides than by a single enzyme digestion. 
This in turn led to a more than 10% increase in sequence coverage under the experimental 
conditions used. Such an increase is particularly important for differentiating the subtypes 
and toxin variants of BoNT, where high-coverage of the BoNT sequence is often required 
for the confident determination of a small number of amino acid variations between different 
subtypes and variants.
In-gel digestion is one of the most commonly used methods to produce peptides for 
proteomic analysis, and gel electrophoresis followed by in-gel digestion using trypsin or 
other proteases can concentrate and separate proteins in a mixture or in a complex. 
Advantages of in-gel digestion include the separation of proteins of interest from others to 
reduce sample complexity and the removal of interfering contaminants that may affect LC-
MS/MS analysis.
The limitations of in-gel digestion include low digestion efficiency and peptide loss, 
presumably caused by limited accessibility of the enzymes to the proteins embedded in the 
gel matrix and inefficient peptide extraction, respectively.27–28 We speculated that a second 
digestion could further cleave both intact proteins and large fragments yielded from 
incomplete digestion and trapped within the gel. This hypothesis is supported by the 
detection of additional peptides after sequential in-gel digestion that contribute to improved 
sequence coverage of BoNT/A in a gel band (Figure 1, Table 2). As expected, substantial 
improvement in the protein sequence coverage resulted from a second tryptic digestion on 
the BoNT gel bands that had already undergone the first cleavage by chymotrypsin, Lys-C, 
and Asp-N, respectively. In addition, we observed that a total of three sequential digestions 
on a gel band was the optimal method to obtain the highest sequence coverage. In this way, 
several sequential digestions can efficiently overcome in-gel digestion’s main disadvantage 
while retaining the advantages.
Sequential digestions add a unique feature to the in-gel digestion method. It is not unusual to 
use a mixture of two proteases, such as trypsin and chymotrypsin, in an in-solution digestion 
for improving protein coverage. Typically two enzymes are added simultaneously in the 
same reaction solution, and the two sets of peptide digests cannot be separated. This may 
cause problems in that some of the MS detectable peptides resulting from the digestion with 
one protease may be cleaved to smaller, undetectable pieces by another. Therefore, the 
protein sequence covered by these peptides might become undetermined which is a 
particular concern in regions of the protein containing abundant cleavage sites. By contrast, 
sequential in-gel digestion allows multiple digestions to be carried out separately. This is 
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particularly important for situations where determining post-translation modifications on a 
protein is desirable, or where only a limited sample quantity is available to differentiate 
protein isoforms. Because the MESID method is not restricted to a particular subject, it can 
be applied to the in-gel digestion of any protein sample and will likely find a broad 
application in proteomics.
We also investigated the effect of multi-enzyme digestion on the same sample at the second 
digestion step. On the assumption that the intact protein or large fragments from the first 
digestion are evenly embedded in the gel matrix, splitting of the gel particles of a given gel 
band for the second digestion with two different proteases might result in complementary 
results. In comparison with applying multiple enzymes on several identical samples, 
sequential digestion of one sample with different enzymes achieved similar effects but use 
less protein. In some sets of sequential digestions (Table 2), the combination of two separate 
second cleavages led to merged sequence coverage higher than those obtained from each of 
the digestions individually.
Conclusion
We have developed an efficient method for the subtyping of botulinum neurotoxins. In this 
study, multiple proteases used for in-gel digestion of the toxin produced complimentary 
results to increase sequence coverage of the toxin. Up to three sequential digestions on a 
single gel band with various enzymes significantly improved the BoNT sequence coverage. 
We applied the strategy of different combinations of multi-enzyme and sequential digestion 
to seven BoNT serotypes. More than 90% of the sequence coverage was accomplished for 
all of these proteins that have the size of approximately 150 kDa. The very high coverage of 
the toxin sequence should allow confident determination of BoNT subtypes or at least 
narrow down the range of potential toxin variant candidates to aid epidemiologic responses 
to botulism outbreaks. Application of the MESID method on a BoNT-contaminated carrot 
juice sample identified the 98.6% sequence of the toxin variant. The generation and 
identification of the peptides covering the amino acid residues unique to a specific subtype 
and toxin variant of BoNTs may provide useful candidates for the development of high-
throughput, highly sensitive, and quantitative methods using advance techniques such as 
multiple-reactions-monitoring (MRM) for rapid BoNT subtyping.
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Figure 1. 
In-gel digestion of BoNT/A (~0.1μg per set) with 4 sets of protease combinations. Each set 
of the digestions was performed sequentially on the same gel band. All digestion reactions 
were carried out at 52°C for 10 min. T: Trypsin, C: Chymotrypsin, L: Lys-C, A: Asp-N.
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Figure 2. 
Sequence coverage yielded from three sequential in-gel digestion on the two identical 
BoNT/A gel bands, with and without guanidination treatment. Digestion conditions were 
identical for two samples (see table 3).
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Figure 3. 
Sequence alignment of identified BoNT/A1 of ABY56330 (top row), and its two homologue 
toxin variant ABZ80564 (middle row) and YP_001383190 (bottom row). Bold letters 
represent identified sequence region. Red bold indicates the variable amino acid residues.
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Table 1
Sequence coverage and unique amino acid residues of BoNT/A1 detected by digestion with specific 
proteasesa.
Enzyme Condition SC (%) Unique residues SC from in-silico digestion (%)b
Trypsin 37°C/ON 59 287 71
Chymotrypsin 25°C/ON 27 75 50
Asp-N 37°C/ON 24 55 44
Lys-C 37°C/ON 15 11 53
Arg-C 37°C/ON 7 0 25
Glu-C 37°C/ON 1 0 30
Overlapped 72
aSix gel bands containing the same amount (loaded 0.14 μg toxin complex) of the BoNT/A protein were digested with different proteases 
separately. SC: sequence coverage; ON: overnight.
bSequence covered by the peptides derived from theoretical digestion of the toxin protein, based on enzyme specificity and protein sequence. 
Peptides ranging from 800 Da to 3000 Da were selected for covered sequence.
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Table 3
Sequence coverage of different in-gel digestion combinations. Data were obtained from the same experiments 
described in Table S1.
Combination
Digestion
1st 2nd 3rd
S1+S2 88 89 89
S1+S3 83 92 92
S1+S4 93 97 97
S2+S3 86 92 94
S2+S4 81 96 97
S3+S4 89 97 97
S1+S2+S3 92 94 95
S1+S2+S4 97 98 98
S1+S3+S4 94 97 97
S2+S3+S4 95 98 98
S1+S2+S3+S4 97 98 99
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Table 4
Proteins identified from commercially available samples of the seven BoNT serotypes (in complex forms).
Protein name M.W. (kDa) GenBank Accession No MASCOT score SC (%)
Botulinum neurotoxin type A1 149 YP_001386738 42468 99
Botulinum neurotoxin B1 151 YP_001693307 20159 95
Botulinum neurotoxin type C1 149 YP_398516 13242 90
Neurotoxin D 147 BAA90661 34227 96
Botulinum neurotoxin type E 143 BAB86845 53001 92
Neurotoxin type F 147 AAA23210 18551 97
Botulinum neurotoxin type G 149 CAA52275 10471 91
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